The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Open accessAbstract
Vascular endothelial growth factor-A (VEGF-A) is a key mediator of angiogenesis, signalling via the class IV tyrosine kinase receptor family of VEGF Receptors (VEGFRs). Although VEGF-A ligands bind to both VEGFR1 and VEGFR2, they primarily signal via VEGFR2 leading to endothelial cell proliferation, survival, migration and vascular permeability. Distinct VEGF-A isoforms result from alternative splicing of the Vegfa gene at exon 8, resulting in VEGFxxxa or VEGFxxxb isoforms. Alternative splicing events at exons 5–7, in addition to recently identified posttranslational read-through events, produce VEGF-A isoforms that differ in their bioavailability and interaction with the co-receptor Neuropilin-1. This review explores the molecular pharmacology of VEGF-A isoforms at VEGFR2 in respect to ligand binding and downstream signalling. To understand how VEGF-A isoforms have distinct signalling despite similar affinities for VEGFR2, this review re-evaluates the typical classification of these isoforms relative to the prototypical, “pro-angiogenic” VEGF165a. We also examine the molecular mechanisms underpinning the regulation of VEGF-A isoform signalling and the importance of interactions with other membrane and extracellular matrix proteins. As approved therapeutics targeting the VEGF-A/VEGFR signalling axis largely lack long-term efficacy, understanding these isoform-specific mechanisms could aid future drug discovery efforts targeting VEGF receptor pharmacology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981 · cited 1×
“VEGF-A transcription is affected by the local cellular environment, such as during hypoxia [48,49] following secretion of growth factors, cytokines and hormones, shear stress, genotoxic agents [50] and the activity of both oncogenes and tumour suppressor genes [51].”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M., & Asahara, T. (1999) · Nature Medicine · doi:10.1038/7434 · Cited by 2,423
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Angiogenesis: an organizing principle for drug discovery?
Folkman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2115 · Cited by 2,246
Gerber, H.-P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30336 · Cited by 1,981
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Signal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Mechanisms and regulation of endothelial VEGF receptor signalling
Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,365
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis
Wang, Y., Nakayama, M., Pitulescu, M. E., Schmidt, T. S., Bochenek, M. L., Sakakibara, A., Adams, S., Davy, A., Deutsch, U., Lüthi, U., et al. (2010) · Nature · doi:10.1038/nature09002 · Cited by 1,271
Goel, H. L., & Mercurio, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3627 · Cited by 1,253
A MODIFICATION OF RECEPTOR THEORY
STEPHENSON, R. P. (1956) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1956.tb00006.x · Cited by 1,156
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair
Johnson, K. E., & Wilgus, T. A. (2014) · Advances in Wound Care · doi:10.1089/wound.2013.0517 · Cited by 1,100
Liu, Y., Cox, S. R., Morita, T., & Kourembanas, S. (1995) · Circulation Research · doi:10.1161/01.res.77.3.638 · Cited by 1,040
Ten years of anti-vascular endothelial growth factor therapy
Ferrara, N., & Adamis, A. P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.17 · Cited by 1,030
Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., & Senger, D. R. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.2.211 · Cited by 898
Nissen, N., Polverini, P. J., Koch, A. E., Volin, M. V., Gamelli, R. L., & DiPietro, L. A. (1998) · Europe PMC (PubMed Central) · Cited by 842
A requirement for neuropilin-1 in embryonic vessel formation
Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., & Fujisawa, H. (1999) · Development · doi:10.1242/dev.126.21.4895 · Cited by 827
Shibuya, M. (2013) · Journal of Biochemistry · doi:10.1093/jb/mvs136 · Cited by 792
Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F., et al. (2003) · Nature Medicine · doi:10.1038/nm884 · Cited by 773
Takahashi, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2768 · Cited by 749
Neuropilin-1 Conveys Semaphorin and VEGF Signaling during Neural and Cardiovascular Development
Gu, C., Rodriguez, E. R., Reimert, D. V., Shu, T., Fritzsch, B., Richards, L. J., Kolodkin, A. L., & Ginty, D. D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00169-2 · Cited by 712
Myosin VI is an actin-based motor that moves backwards
Wells, A. L., Lin, A. W., Chen, L.-Q., Safer, D., Cain, S. M., Hasson, T., Carragher, B. O., Milligan, R. A., & Sweeney, H. L. (1999) · Nature · doi:10.1038/46835 · Cited by 681
Neubig, R. R., Spedding, M., Kenakin, T., & Christopoulos, A. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.4 · Cited by 665
Kitsukawa, T., Shimizu, M., Sanbo, M., Hirata, T., Taniguchi, M., Bekku, Y., Yagi, T., & Fujisawa, H. (1997) · Neuron · doi:10.1016/s0896-6273(00)80392-x · Cited by 656
Senger, D. R., Perruzzi, C. A., Feder, J., & Dvorak, H. F. (1986) · PubMed · Cited by 646
Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)
Gille, H., Kowalski, J., Li, B., LeCouter, J., Moffat, B., Zioncheck, T. F., Pelletier, N., & Ferrara, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002016200 · Cited by 620
Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R., & Ferrara, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7788 · Cited by 604
Banks, R., Forbes, M., Kinsey, S., Stanley, A., Ingham, E., Walters, C., & Selby, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.158 · Cited by 599
Takahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
(2002) · PubMed · Cited by 550
Brogi, E., Wu, T., Namiki, A., & Isner, J. M. (1994) · Circulation · doi:10.1161/01.cir.90.2.649 · Cited by 546
Lampugnani, M. G., Orsenigo, F., Gagliani, M. C., Tacchetti, C., & Dejana, E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200602080 · Cited by 525
Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T., & Shibuya, M. (2001) · Blood · doi:10.1182/blood.v97.3.785 · Cited by 500
Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells
Namiki, A., Brogi, E., Kearney, M., Kim, E. A., Wu, T., Couffinhal, T., Varticovski, L., & Isner, J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31189 · Cited by 492
Gitay-Goren, H., Soker, S., Vlodavsky, I., & Neufeld, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42666-x · Cited by 490
Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor
Wiesmann, C., Fuh, G., Christinger, H. W., Eigenbrot, C., Wells, J. A., & de Vos, A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80456-0 · Cited by 486
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
Self-citationTepper, O. M., Capla, J. M., Galiano, R. D., Ceradini, D. J., Callaghan, M. J., Kleinman, M. E., & Gurtner, G. C. (2005) · Blood · doi:10.1182/blood-2004-03-1051 · Cited by 445
Imaging Sites of Receptor Dephosphorylation by PTP1B on the Surface of the Endoplasmic Reticulum
Haj, F. G., Verveer, P. J., Squire, A., Neel, B. G., & Bastiaens, P. I. H. (2002) · Science · doi:10.1126/science.1067566 · Cited by 434
Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y., & Shibuya, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31273 · Cited by 406
Vascular Endothelial Growth Factor A in Intraocular Vascular Disease
Miller, J. W., Le Couter, J., Strauss, E. C., & Ferrara, N. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.038 · Cited by 406
Endosomes: A legitimate platform for the signaling train
Murphy, J. E., Padilla, B. E., Hasdemir, B., Cottrell, G. S., & Bunnett, N. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906541106 · Cited by 373
Flk-1 expression defines a population of early embryonic hematopoietic precursors
Kabrun, N., Bühring, H.-J., Choi, K., Ullrich, A., Risau, W., & Keller, G. (1990) · Development · doi:10.1242/dev.124.10.2039 · Cited by 354
Sun, X., Yang, S., & Zhao, J. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s97653 · Cited by 347
Intracellular Pool of Vascular Endothelial Growth Factor in Human Neutrophils
Gaudry, M., Brégerie, O., Andrieu, V., El Benna, J., Pocidalo, M.-A., & Hakim, J. (1997) · Blood · doi:10.1182/blood.v90.10.4153 · Cited by 345
VEGF-Induced Vascular Permeability Is Mediated by FAK
Chen, X. L., Nam, J.-O., Jean, C., Lawson, C., Walsh, C. T., Goka, E., Lim, S.-T., Tomar, A., Tancioni, I., Uryu, S., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2011.11.002 · Cited by 341
Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J., & Bates, D. O. (2008) · Journal of Cell Science · doi:10.1242/jcs.016410 · Cited by 339
Self-citationExtracellular regulation of VEGF: Isoforms, proteolysis, and vascular patterning
Vempati, P., Popel, A. S., & Mac Gabhann, F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.11.002 · Cited by 313
The Interaction of Neuropilin-1 with Vascular Endothelial Growth Factor and Its Receptor Flt-1
Fuh, G., Garcia, K. C., & de Vos, A. M. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61431-6 · Cited by 312
Franco, M., Roswall, P., Cortez, E., Hanahan, D., & Pietras, K. (2011) · Blood · doi:10.1182/blood-2011-01-331694 · Cited by 310
Kim, K. J., Li, B., Houck, K., Winer, J., & Ferrara, N. (1992) · Growth Factors · doi:10.3109/08977199209023937 · Cited by 306
Unbalanced alternative splicing and its significance in cancer
Venables, J. P. (2006) · BioEssays · doi:10.1002/bies.20390 · Cited by 299
Coon, B. G., Baeyens, N., Han, J., Budatha, M., Ross, T. D., Fang, J. S., Yun, S., Thomas, J.-L., & Schwartz, M. A. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201408103 · Cited by 299
Whitaker, G. B., Limberg, B. J., & Rosenbaum, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102315200 · Cited by 294
Galandrin, S., & Bouvier, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026716 · Cited by 291
Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
Cao, Y. (2009) · Science Signaling · doi:10.1126/scisignal.259re1 · Cited by 289
Dixelius, J., Mäkinen, T., Wirzenius, M., Karkkainen, M. J., Wernstedt, C., Alitalo, K., & Claesson-Welsh, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304499200 · Cited by 284
Bussolati, B., Dunk, C., Grohman, M., Kontos, C. D., Mason, J., & Ahmed, A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61775-0 · Cited by 284
Cai, H., & Reed, R. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06519.1999 · Cited by 279
VEGF receptor protein–tyrosine kinases: Structure and regulation
Roskoski, R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.121 · Cited by 269
Holmqvist, K., Cross, M. J., Rolny, C., Hägerkvist, R., Rahimi, N., Matsumoto, T., Claesson-Welsh, L., & Welsh, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312729200 · Cited by 265
Mamluk, R., Gechtman, Z., Kutcher, M. E., Gasiunas, N., Gallagher, J., & Klagsbrun, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200730200 · Cited by 260
Application of BRET to monitor ligand binding to GPCRs
Stoddart, L. A., Johnstone, E. K. M., Wheal, A. J., Goulding, J., Robers, M. B., Machleidt, T., Wood, K. V., Hill, S. J., & Pfleger, K. D. G. (2015) · Nature Methods · doi:10.1038/nmeth.3398 · Cited by 248
Self-citationProgrammed Translational Readthrough Generates Antiangiogenic VEGF-Ax
Eswarappa, S. M., Potdar, A. A., Koch, W. J., Fan, Y., Vasu, K., Lindner, D., Willard, B., Graham, L. M., DiCorleto, P. E., & Fox, P. L. (2014) · Cell · doi:10.1016/j.cell.2014.04.033 · Cited by 236
Rahimi, N., Dayanir, V., & Lashkari, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000528200 · Cited by 236
Gu, C., Limberg, B. J., Whitaker, G. B., Perman, B., Leahy, D. J., Rosenbaum, J. S., Ginty, D. D., & Kolodkin, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201681200 · Cited by 228
Structural basis for ligand and heparin binding to neuropilin B domains
Vander Kooi, C. W., Jusino, M. A., Perman, B., Neau, D. B., Bellamy, H. D., & Leahy, D. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700043104 · Cited by 227
Varey, A. H. R., Rennel, E. S., Qiu, Y., Bevan, H. S., Perrin, R. M., Raffy, S., Dixon, A. R., Paraskeva, C., Zaccheo, O., Hassan, A. B., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604308 · Cited by 226
Expression of vascular endothelial growth factor receptors in smooth muscle cells
Ishida, A., Murray, J., Saito, Y., Kanthou, C., Benzakour, O., Shibuya, M., & Wijelath, E. S. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1121 · Cited by 220
Appleton, B. A., Wu, P., Maloney, J., Yin, J., Liang, W., Stawicki, S., Mortara, K., Bowman, K. K., Elliott, J. M., Desmarais, W., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601906 · Cited by 216
Neuropilin-1 Binds to VEGF121 and Regulates Endothelial Cell Migration and Sprouting
Pan, Q., Chathery, Y., Wu, Y., Rathore, N., Tong, R. K., Peale, F., Bagri, A., Tessier-Lavigne, M., Koch, A. W., & Watts, R. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703554200 · Cited by 204
The Neuropilin 1 Cytoplasmic Domain Is Required for VEGF-A-Dependent Arteriogenesis
Lanahan, A., Zhang, X., Fantin, A., Zhuang, Z., Rivera-Molina, F., Speichinger, K., Prahst, C., Zhang, J., Wang, Y., Davis, G., et al. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.03.019 · Cited by 204
McTigue, M. A., Wickersham, J. A., Pinko, C., Showalter, R. E., Parast, C. V., Tempczyk-Russell, A., Gehring, M. R., Mroczkowski, B., Kan, C.-C., Villafranca, J. E., et al. (1999) · Structure · doi:10.1016/s0969-2126(99)80042-2 · Cited by 203
Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output
Ballmer-Hofer, K., Andersson, A. E., Ratcliffe, L. E., & Berger, P. (2011) · Blood · doi:10.1182/blood-2011-01-328773 · Cited by 202
Bauer, J., Margolis, M., Schreiner, C., Edgell, C., Azizkhan, J., Lazarowski, E., & Juliano, R. L. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041530302 · Cited by 202
Herzog, B., Pellet-Many, C., Britton, G., Hartzoulakis, B., & Zachary, I. C. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-12-1061 · Cited by 202
Neuropilin Functions as an Essential Cell Surface Receptor
Guo, H.-F., & Vander Kooi, C. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.687327 · Cited by 200
Roles of VEGF-A signalling in development, regeneration, and tumours
Matsumoto, K., & Ema, M. (2014) · Journal of Biochemistry · doi:10.1093/jb/mvu031 · Cited by 198
Cébe Suarez, S., Pieren, M., Cariolato, L., Arn, S., Hoffmann, U., Bogucki, A., Manlius, C., Wood, J., & Ballmer-Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6254-9 · Cited by 198
Solution structure of the heparin-binding domain of vascular endothelial growth factor
Fairbrother, W. J., Champe, M. A., Christinger, H. W., Keyt, B. A., & Starovasnik, M. A. (1998) · Structure · doi:10.1016/s0969-2126(98)00065-3 · Cited by 197
ABU-GHAZALEH, R., Kabir, J., Jia, H., Mel, L. O. B. O., & Zachary, I. C. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600255 · Cited by 197
Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
Li, Y.-L., Li, Y.-L., Zhao, H., Ren, X.-B., Zhao, H., & Ren, X.-B. (2016) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2015.0070 · Cited by 196
Kikuchi, R., Nakamura, K., MacLauchlan, S., Ngo, D. T.-M., Shimizu, I., Fuster, J. J., Katanasaka, Y., Yoshida, S., Qiu, Y., Yamaguchi, T. P., et al. (2014) · Nature Medicine · doi:10.1038/nm.3703 · Cited by 195
Neuropilin‐1 expression in cancer and development
Jubb, A. M., Strickland, L. A., Liu, S. D., Mak, J., Schmidt, M., & Koeppen, H. (2012) · The Journal of Pathology · doi:10.1002/path.2989 · Cited by 188
Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1
Parker, M. W., Xu, P., Li, X., & Vander Kooi, C. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.331140 · Cited by 186
VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts
Nilsson, I., Bahram, F., Li, X., Gualandi, L., Koch, S., Jarvius, M., Söderberg, O., Anisimov, A., Kholová, I., Pytowski, B., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.30 · Cited by 184
Ewan, L. C., Jopling, H. M., Jia, H., Mittar, S., Bagherzadeh, A., Howell, G. J., Walker, J. H., Zachary, I. C., & Ponnambalam, S. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00462.x · Cited by 183
Ashikari-Hada, S., Habuchi, H., Kariya, Y., & Kimata, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414581200 · Cited by 183
VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment
Gampel, A., Moss, L., Jones, M. C., Brunton, V., Norman, J. C., & Mellor, H. (2006) · Blood · doi:10.1182/blood-2005-12-007484 · Cited by 181
Role of the VEGF/VEGFR Axis in Cancer Biology and Therapy
(2012) · Advances in Cancer Research · doi:10.1016/b978-0-12-386503-8.00006-5 · Cited by 180
Structural determinants of growth factor binding and specificity by VEGF receptor 2
Leppänen, V.-M., Prota, A. E., Jeltsch, M., Anisimov, A., Kalkkinen, N., Strandin, T., Lankinen, H., Goldman, A., Ballmer-Hofer, K., & Alitalo, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914318107 · Cited by 177
Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates
Lee, M. Y., Luciano, A. K., Ackah, E., Rodriguez-Vita, J., Bancroft, T. A., Eichmann, A., Simons, M., Kyriakides, T. R., Morales-Ruiz, M., & Sessa, W. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408472111 · Cited by 176
Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity
Woolard, J., Bevan, H. S., Harper, S. J., & Bates, D. O. (2009) · Microcirculation · doi:10.1080/10739680902997333 · Cited by 176
Self-citationTargeting VEGF in eye neovascularization: What's new?
Amadio, M., Govoni, S., & Pascale, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.027 · Cited by 175
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
Schmidinger, M. (2013) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2013.07.016 · Cited by 170
Starzec, A., Vassy, R., Martin, A., Lecouvey, M., Di Benedetto, M., Crépin, M., & Perret, G. Y. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.08.005 · Cited by 167
The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13353 · Cited by 159
Alternative splicing in angiogenesis: The vascular endothelial growth factor paradigm
Ladomery, M., Harper, S. J., & Bates, D. O. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.08.015 · Cited by 158
Cudmore, M. J., Hewett, P. W., Ahmad, S., Wang, K.-Q., Cai, M., Al-Ani, B., Fujisawa, T., Ma, B., Sissaoui, S., Ramma, W., et al. (2012) · Nature Communications · doi:10.1038/ncomms1977 · Cited by 158
Expression of Vascular Endothelial Growth Factor Receptors 1, 2, and 3 in Quiescent Endothelia
Witmer, A. N., Dai, J., Weich, H. A., Vrensen, G. F. J. M., & Schlingemann, R. O. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000603 · Cited by 157
Kawamura, H., Li, X., Harper, S. J., Bates, D. O., & Claesson-Welsh, L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6577 · Cited by 156
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
Gammons, M. V. R., Lucas, R., Dean, R., Coupland, S. E., Oltean, S., & Bates, D. O. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.342 · Cited by 155
Structure of a VEGF–VEGF receptor complex determined by electron microscopy
Ruch, C., Skiniotis, G., Steinmetz, M. O., Walz, T., & Ballmer‐Hofer, K. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1202 · Cited by 155
Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization
Brozzo, M. S., Bjelić, S., Kisko, K., Schleier, T., Leppänen, V., Alitalo, K. K., Winkler, F. K., & Ballmer‐Hofer, K. (2011) · Blood · doi:10.1182/blood-2011-11-390922 · Cited by 154
New concepts in pharmacological efficacy at 7 TM receptors: IUPHAR R eview 2
Kenakin, T. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02223.x · Cited by 153
Naccache, S. N., Hasson, T., & Horowitz, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605317103 · Cited by 153
Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides
Zhao, W., McCallum, S. A., Xiao, Z., Zhang, F., & Linhardt, R. J. (2011) · Bioscience Reports · doi:10.1042/bsr20110077 · Cited by 153
Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers
Huang, K., Andersson, C., Roomans, G. M., Ito, N., & Claesson, L. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00019-x · Cited by 148
Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-binding Domain of Neuropilin-1
Prahst, C., Héroult, M., Lanahan, A. A., Uziel, N., Kessler, O., Shraga‐Heled, N., Simons, M., Neufeld, G., & Augustin, H. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800137200 · Cited by 147
VEGFR-2 conformational switch in response to ligand binding
Sarabipour, S., Ballmer‐Hofer, K., & Hristova, K. A. (2016) · eLife · doi:10.7554/elife.13876 · Cited by 147
Activation of p38 Has Opposing Effects on the Proliferation and Migration of Endothelial Cells
McMullen, M. E., Bryant, P. W., Glembotski, C. C., Vincent, P. A., & Pumiglia, K. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407060200 · Cited by 143
Dimerization of VEGF receptors and implications for signal transduction: A computational study
Gabhann, F. M., & Popel, A. S. (2007) · Biophysical Chemistry · doi:10.1016/j.bpc.2007.03.010 · Cited by 142
Simon, M., Röckl, W., Hornig, C., Gröne, E., Theis, H., Weich, H. A., Fuchs, E., Yayon, A., & Gröne, H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v961032 · Cited by 141
VEGFR and Type-V RTK Activation and SignalingPreprint
Shibuya, M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009092 · Cited by 141
Angiogenesis in Inflammatory Bowel Disease
Alkim, C. A., Alkım, H., Köksal, A. R., Boğa, S., & Şen, İ. (2015) · International Journal of Inflammation · doi:10.1155/2015/970890 · Cited by 140
Ligand‐Stimulated VEGFR2 Signaling is Regulated by Co‐Ordinated Trafficking and Proteolysis
Bruns, A. F., Herbert, S. P., Odell, A. F., Jopling, H. M., Hooper, N. M., Zachary, I. C., Walker, J. H., & Ponnambalam, S. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.01001.x · Cited by 139
Selective Regulation of Arterial Branching Morphogenesis by Synectin
Chittenden, T. W., Claes, F., Lanahan, A. A., Autiero, M., Palac, R. T., Tkachenko, E., Elfenbein, A., de Almodóvar, C. R., Dedkov, E. I., Tomanek, R. J., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.012 · Cited by 137
Neuropilin-1 Regulates Vascular Endothelial Growth Factor–Mediated Endothelial Permeability
Becker, P. M., Waltenberger, J. L., Yachechko, R., Mirzapoiazova, T., Sham, J. S. K., Lee, C. G., Elias, J. A., & Verin, A. D. (2005) · Circulation Research · doi:10.1161/01.res.0000171756.13554.49 · Cited by 137
Neagoe, P., Lemieux, C., & Sirois, M. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412017200 · Cited by 133
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
Pritchard‐Jones, R., Dunn, D., Qiu, Y., Varey, A. H. R., Orlando, A., Rigby, H., Harper, S. J., & Bates, D. O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603839 · Cited by 133
The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
Rennel, E. S., Waine, E., Guan, H., Schüler, Y., Leenders, W. P. J., Woolard, J., Sugiono, M., Gillatt, D. A., Kleinerman, E. S., Bates, D. O., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604309 · Cited by 131
Self-citationWang, X., Mukhopadhyay, D., & Xu, X. (2006) · The FASEB Journal · doi:10.1096/fj.05-5504fje · Cited by 128
von Wronski, M. A., Raju, N., Pillai, R. M., Bogdan, N. J., Marinelli, E. R., Nanjappan, P., Ramalingam, K., Arunachalam, T., Eaton, S., Linder, K. E., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511941200 · Cited by 128
Yamazaki, Y., Matsunaga, Y., Tokunaga, Y., Obayashi, S., Saito, M., & Morita, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809071200 · Cited by 123
Quantification and cell-to-cell variation of vascular endothelial growth factor receptors
Imoukhuede, P. I., & Popel, A. S. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.12.014 · Cited by 121
Iyer, S., & Acharya, K. R. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08350.x · Cited by 120
Targeting VEGF signalling via the neuropilin co-receptor
Djordjević, S., & Driscoll, P. C. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.11.013 · Cited by 118
Starzec, A. B., Ladam, P., Vassy, R., Badache, S., Bouchemal, N., Navaza, A., du Penhoat, C. H., & Perret, G. Y. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.013 · Cited by 118
Fantin, A., Schwarz, Q., Davidson, K., Normando, E. M., Denti, L., & Ruhrberg, C. (2011) · Development · doi:10.1242/dev.070037 · Cited by 118
NanoBRET Approaches to Study Ligand Binding to GPCRs and RTKs
Stoddart, L. A., Kilpatrick, L. E., & Hill, S. J. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.10.006 · Cited by 118
Self-citationBatson, J., Toop, H. D., Redondo, C., Babaei‐Jadidi, R., Chaikuad, A., Wearmouth, S., Gibbons, B., Allen, C., Tallant, C., Zhang, J., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01048 · Cited by 116
Basagiannis, D., Zografou, S., Murphy, C., Fotsis, T., Morbidelli, L., Ziche, M., Bleck, C. K. E., Mercer, J., & Christoforidis, S. (2016) · Journal of Cell Science · doi:10.1242/jcs.188219 · Cited by 115
Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A
Markovic-Mueller, S., Stuttfeld, E., Asthana, M., Weinert, T., Bliven, S. E., Goldie, K. N., Kisko, K., Capitani, G., & Ballmer‐Hofer, K. (2017) · Structure · doi:10.1016/j.str.2016.12.012 · Cited by 113
Heparan Sulfate Regulates VEGF165- and VEGF121-mediated Vascular Hyperpermeability
Xu, D., Fuster, M. M., Lawrence, R., & Esko, J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177006 · Cited by 112
Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
Comunanza, V., & Bussolino, F. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00101 · Cited by 109
Lanahan, A. A., Lech, D., Dubrac, A., Zhang, J., Zhuang, Z. W., Eichmann, A., & Simons, M. (2014) · Circulation · doi:10.1161/circulationaha.114.009683 · Cited by 108
Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain
Krilleke, D., DeErkenez, A., Schubert, W., Giri, I., Robinson, G. S., Ng, Y., & Shima, D. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700319200 · Cited by 106
Yang, Y., Xie, P., Opatowsky, Y., & Schlessinger, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914052107 · Cited by 102
Angiogenesis in Psoriasis: Therapeutic Implications
Folkman, J. (1972) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12625746 · Cited by 101
Mineur, P., Colige, A., Deroanne, C., Dubail, J., Kesteloot, F., Habraken, Y., Noël, A., Vöö, S. A., Waltenberger, J. L., Lapiere, C. M., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703052 · Cited by 98
Koch, S., van Meeteren, L. A., Morin, E., Testini, C., Weström, S., Björkelund, H., Jan, S. L., Adler, J., Berger, P., & Claesson, L. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.02.010 · Cited by 95
Function of Members of the Neuropilin Family as Essential Pleiotropic Cell Surface Receptors
Parker, M. W., Guo, H., Li, X., Linkugel, A. D., & Kooi, C. W. V. (2012) · Biochemistry · doi:10.1021/bi3012143 · Cited by 95
Allosteric targeting of receptor tyrosine kinases
Smet, F. D., Christopoulos, A., & Carmeliet, P. (2014) · Nature Biotechnology · doi:10.1038/nbt.3028 · Cited by 92
Ganta, V. C., Choi, M., Kutateladze, A. A., & Annex, B. H. (2016) · Circulation Research · doi:10.1161/circresaha.116.309516 · Cited by 92
VEGF Signaling in Cancer Treatment
Sia, D., Alsinet, C., Newell, P., & Villanueva, A. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990590 · Cited by 90
Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis
Barratt, S. L., Blythe, T., Jarrett, C., Ourradi, K., Shelley‐Fraser, G., Day, M. J., Qiu, Y., Harper, S. J., Maher, T. M., Oltean, S., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201603-0568oc · Cited by 88
Teran, M., & Nugent, M. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627372 · Cited by 87
Gourlaouen, M., Welti, J. C., Vasudev, N. S., & Reynolds, A. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.446401 · Cited by 87
Meyer, R., Mohammadi, M., & Rahimi, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506454200 · Cited by 86
VEGF and the diabetic kidney: More than too much of a good thing
Majumder, S., & Advani, A. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.020 · Cited by 81
Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling
Simon, T. R., Gagliano, T., & Giamas, G. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.01.002 · Cited by 81
Evidence for Pro-angiogenic Functions of VEGF-Ax
Xin, H., Zhong, C., Nudleman, E., & Ferrara, N. (2016) · Cell · doi:10.1016/j.cell.2016.08.054 · Cited by 80
VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A
Catena, R., Larzábal, L., Larráyoz, M., Molina, E., Hermida, J., Agorreta, J., Montes, R., Pı́o, R., Montuenga, L. M., & Calvo, A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-320 · Cited by 79
Hervé, M.-A., Buteau-Lozano, H., Mourah, S., Calvo, F. M., & Perrot‐Applanat, M. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.05.022 · Cited by 78
Diabetic macular oedema: pathophysiology, management challenges and treatment resistance
Bahrami, B., Zhu, M., Hong, T., & Chang, A. (2016) · Diabetologia · doi:10.1007/s00125-016-3974-8 · Cited by 75
Jopling, H. M., Odell, A. F., Pellet‐Many, C., Latham, A. M., Frankel, P., Sivaprasadarao, A., Walker, J. H., Zachary, I. C., & Ponnambalam, S. (2014) · Cells · doi:10.3390/cells3020363 · Cited by 74
Reed, B. C., Cefalu, C., Bellaire, B. H., Cardelli, J. A., Louis, T., Salamon, J. A., Bloecher, M. A., & Bunn, R. C. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-0978 · Cited by 71
Smith, G. A., Fearnley, G. W., Tomlinson, D. C., Harrison, M. A., & Ponnambalam, S. (2015) · Bioscience Reports · doi:10.1042/bsr20150171 · Cited by 69
Delcombel, R., Janssen, L., Vassy, R., Gammons, M. V. R., Haddad, O., Richard, B., Letourneur, D., Bates, D. O., Hendricks, C., Waltenberger, J. L., et al. (2012) · Angiogenesis · doi:10.1007/s10456-012-9320-y · Cited by 69
SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases
Oltean, S., Gammons, M. V. R., Hulse, R. P., Hamdollah‐Zadeh, M., Mavrou, A., Donaldson, L. F., Salmon, A. H. J., Harper, S. J., Ladomery, M., & Bates, D. O. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120051 · Cited by 67
The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling
Jopling, H. M., Howell, G. J., Gamper, N. L., & Ponnambalam, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.093 · Cited by 66
The potential role of angiogenic factors in rheumatoid arthritis
Azizi, G., Boghozian, R., & Mirshafiey, A. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12280 · Cited by 65
Ocular Angiogenesis: Vascular Endothelial Growth Factor and Other Factors
Rubio, R. G., & Adamis, A. P. (2015) · Developments in ophthalmology · doi:10.1159/000431129 · Cited by 65
Hulse, R. P., Beazley‐Long, N., Ved, N., Bestall, S. M., Riaz, H., Singhal, P., Ballmer-Hofer, K., Harper, S. J., Bates, D. O., & Donaldson, L. F. (2015) · Clinical Science · doi:10.1042/cs20150124 · Cited by 62
VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysis
Fearnley, G. W., Smith, G. A., Abdul‐Zani, I., Yuldasheva, N. Y., Mughal, N. A., Homer‐Vanniasinkam, S., Kearney, M. T., Zachary, I. C., Tomlinson, D. C., Harrison, M. A., et al. (2016) · Biology Open · doi:10.1242/bio.017434 · Cited by 62
Clegg, L. E., & Gabhann, F. M. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004158 · Cited by 58
Constitutive Endocytosis of VEGFR2 Protects the Receptor against Shedding
Basagiannis, D., & Christoforidis, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730309 · Cited by 58
Guyot, M., & Pagès, G. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2917-7_1 · Cited by 56
Starovasnik, M. A., Christinger, H. W., Wiesmann, C., Champe, M., de Vos, A. M., & Skelton, N. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3134 · Cited by 56
Shang, G., Brautigam, C. A., Chen, R., Lu, D., Torres‐Vázquez, J., & Zhang, X. (2017) · eLife · doi:10.7554/elife.27322 · Cited by 56
Protocatechuic Acid Induces Angiogenesis through P I3 K ‐ A kt‐e NOS ‐ VEGF Signalling Pathway
Kang, Z.-C., Zhu, H., Jiang, W., & Zhang, S. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12094 · Cited by 55
Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale
Harris, S., Craze, M. L., Newton, J., Fisher, M. L., Shima, D. T., Tozer, G. M., & Kanthou, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035231 · Cited by 53
Kilpatrick, L. E., Ohana, R. F., Alcobia, D. C., Riching, K. M., Peach, C. J., Wheal, A. J., Briddon, S. J., Robers, M. B., Zimmerman, K., Machleidt, T., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.006 · Cited by 53
Self-citationMechanism of Selective VEGF-A Binding by Neuropilin-1 Reveals a Basis for Specific Ligand Inhibition
Parker, M. W., Xu, P., Guo, H., & Kooi, C. W. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049177 · Cited by 52
Transmembrane domain‐mediated orientation of receptor monomers in active VEGFR‐2 dimers
Dell'Era-Dosch, D., & Ballmer‐Hofer, K. (2009) · The FASEB Journal · doi:10.1096/fj.09-132670 · Cited by 49
Fearnley, G. W., Odell, A. F., Latham, A. M., Mughal, N. A., Bruns, A. F., Burgoyne, N. J., Homer‐Vanniasinkam, S., Zachary, I. C., Hollstein, M. C., Wheatcroft, S. B., et al. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-0962 · Cited by 49
Manni, S., Mineev, K. S., Usmanova, D. R., Lyukmanova, E. N., Shulepko, M. A., Kirpichnikov, M. P., Winter, J., Matkovic, M., Deupí, X., Arseniev, A. S., et al. (2014) · Structure · doi:10.1016/j.str.2014.05.010 · Cited by 49
Muller, Y. A., Heiring, C., Misselwitz, R., Welfle, K., & Welfle, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206438200 · Cited by 49
Titomanlio, L., Fernández‐López, D., Manganozzi, L., Moretti, R., Vexler, Z. S., & Gressèns, P. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2015.01.016 · Cited by 47
Expression of Integrins and Adhesive Properties of Human Endothelial Cell Line EA.hy 926.
Barańska, P., Jerczyńska, H., Pawłowska, Z., Koziołkiewicz, W., & Cierniewski, C. S. (2005) · PubMed · Cited by 47
Ved, N., Hulse, R. P., Bestall, S. M., Donaldson, L. F., Bainbridge, J. W., & Bates, D. O. (2017) · Clinical Science · doi:10.1042/cs20170102 · Cited by 45
Tillo, M., Erskine, L., Cariboni, A. M., Fantin, A., Joyce, A., Denti, L., & Ruhrberg, C. (2014) · Development · doi:10.1242/dev.115998 · Cited by 44
Hyde, C. A. C., Giese, A., Stuttfeld, E., Abram-Saliba, J., Villemagne, D., Schleier, T., Binz, H. K., & Ballmer‐Hofer, K. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06787-11 · Cited by 43
Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
Stevens, M., & Oltean, S. (2018) · Genes · doi:10.3390/genes9020098 · Cited by 43
VEGFR2 Trafficking, Signaling and Proteolysis is Regulated by the Ubiquitin Isopeptidase USP8
Smith, G. A., Fearnley, G. W., Abdul‐Zani, I., Wheatcroft, S. B., Tomlinson, D. C., Harrison, M. A., & Ponnambalam, S. (2015) · Traffic · doi:10.1111/tra.12341 · Cited by 40
Lee, T.-Y., Folkman, J., & Javaherian, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009945 · Cited by 39
Dynasore impairs VEGFR2 signalling in an endocytosis-independent manner
Basagiannis, D., Zografou, S., Galanopoulou, K., & Christoforidis, S. (2017) · Scientific Reports · doi:10.1038/srep45035 · Cited by 39
Ourradi, K., Blythe, T., Jarrett, C., Barratt, S. L., Welsh, G. I., & Millar, A. (2017) · Respiratory Research · doi:10.1186/s12931-017-0602-1 · Cited by 39
Architecture and hydration of the arginine‐binding site of neuropilin‐1
Mota, F., Fotinou, C., Rana, R. R., Chan, A. W. E., Yelland, T., Arooz, M. T., O'Leary, A. P., Hutton, J. A., Frankel, P., Zachary, I. C., et al. (2018) · FEBS Journal · doi:10.1111/febs.14405 · Cited by 37
Cited by
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Nanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesis
Nosrati, H., Aramideh Khouy, R., Nosrati, A., Khodaei, M., Banitalebi-Dehkordi, M., Ashrafi-Dehkordi, K., Sanami, S., & Alizadeh, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00755-7 · Cited by 720
Lee, C., Kim, M.-J., Kumar, A., Lee, H.-W., Yang, Y., & Kim, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02249-0 · Cited by 365
VEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Zhang, J., Zhang, J., Zhang, C., Zhang, J., Gu, L., Luo, D., & Qiu, Q. (2022) · Cells · doi:10.3390/cells11213362 · Cited by 300
Metadata
- Authors
- Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., & Woolard, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-04-23
- Volume
- 19
- Issue
- 4
- Pages
- 1264
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2802868810
- Cited by
- 512
- References
- 219
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.